Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label Study to Evaluate the Effectiveness and Safety of Aripiprazole in Patients With Acute Episode of Schizophrenia

NCT03289026 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT03289026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03289026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label Study to Evaluate the Effectiveness and Safety of Aripiprazole in Patients With Acute Episode of Schizophrenia
Lead sponsor
Peking University
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2017
Completion date
February 2, 2021
Enrollment
770 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acute schizophrenia episode